Gene: PGM1

5236
CDG1T|GSD14
phosphoglucomutase 1
protein-coding
1p31.3
Ensembl:ENSG00000079739 MIM:171900 Vega:OTTHUMG00000008968 UniprotKB:P36871
NG_016966.1
PubMed|SNP Mapped
17   ANCO-SNPs
ND|AD
2   
NA (AD)  NA (ND)   (Frontal_Cortex)
7.281e-1 (AD)  5.298e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs4643chr1:63659768 (GRCh38.p7)A>Calcohol dependenceSNV(Single Nucleotide Variation)
rs8294chr1:63659697 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs11208264chr1:63659401 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2749100chr1:63659308 (GRCh38.p7)G>Talcohol dependenceSNV(Single Nucleotide Variation)
rs12027168chr1:63654942 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2269233chr1:63653675 (GRCh38.p7)T>C / T>Galcohol dependenceSNV(Single Nucleotide Variation)
rs2269234chr1:63653305 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs2269235chr1:63653244 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)
rs2269238chr1:63651866 (GRCh38.p7)G>A / G>Talcohol dependenceSNV(Single Nucleotide Variation)
rs11576729chr1:63648758 (GRCh38.p7)G>A / G>Talcohol dependenceSNV(Single Nucleotide Variation)
rs3790857chr1:63646195 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs2269240chr1:63643593 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2269241chr1:63643100 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2269245chr1:63642222 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs2269246chr1:63641820 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs2269247chr1:63641613 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs2301054chr1:63641357 (GRCh38.p7)A>Galcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CPE0.912
TMBIM60.895
GLUD10.894
BBS20.892
DDAH10.891
SRI0.88
ALDH20.877
SERPINE20.87
ETFA0.868
HTRA10.867

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.715
OR4F29-0.665
OR6C74-0.242
TDGF1-0.217
CETP-0.208
ITIH6-0.201
TRPV5-0.199
C17orf112-0.199
CHP2-0.198
DYNAP-0.197

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB02835Alpha-D-Glucose 1,6-BisphosphateSmall Molecule10139-18-1ExperimentalTarget
DB04397Alpha-D-Glucose-1-Phosphate-6-VanadateSmall MoleculeExperimentalTarget
DB06773Human calcitoninBiotechDrug21215-62-3Approved|InvestigationalEnzyme
ID Drug Name Action PubMed
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of PGM1 mRNA"22698814
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in increased expression of PGM1 mRNA"19114083
C5116212-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA]23152189
C5116212-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in increased expression of PGM1 mRNA23152189
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C0326424-aminophenylarsenoxide4-aminophenylarsenoxide binds to PGM1 protein26598702
C0326424-aminophenylarsenoxidearsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGM1 protein]26598702
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of PGM1 mRNA21420995
D000082AcetaminophenAcetaminophen affects the expression of PGM1 mRNA17562736
D020106AcrylamideAcrylamide results in increased expression of PGM1 mRNA28959563
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of PGM1 mRNA27153756
C011512alpha-naphthoflavonealpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA]23152189
C011512alpha-naphthoflavonealpha-naphthoflavone results in increased expression of PGM1 mRNA23152189
D000643Ammonium ChlorideAmmonium Chloride affects the expression of PGM1 mRNA16483693
D000966Antimony Potassium TartrateAntimony Potassium Tartrate results in increased expression of PGM1 mRNA28713220
C006632arsenic trioxidearsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGM1 protein]26598702
C006632arsenic trioxidearsenic trioxide results in increased expression of PGM1 mRNA20458559
C006632arsenic trioxidearsenic trioxide results in increased expression of PGM1 protein25419056
C006780bisphenol Abisphenol A results in increased expression of PGM1 mRNA29275510
C006780bisphenol Abisphenol A affects the expression of PGM1 mRNA21786754
C006780bisphenol Abisphenol A results in increased expression of PGM1 mRNA25181051
C013418bromfenacoumbromfenacoum results in increased expression of PGM1 protein28903499
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of PGM1 protein21667247
D002110CaffeineCaffeine results in decreased expression of PGM1 mRNA23774253
D002211CapsaicinCapsaicin results in increased expression of PGM1 mRNA19891501
D002211CapsaicinCapsaicin results in increased expression of PGM1 protein19891501
D002211CapsaicinCapsaicin results in decreased expression of PGM1 mRNA20349343
D002220CarbamazepineCarbamazepine results in decreased expression of PGM1 mRNA23774253
C100187chloropicrinchloropicrin results in decreased expression of PGM1 mRNA26352163
D002995Clofibric AcidClofibric Acid affects the expression of PGM1 mRNA17602206
C018021cobaltous chloridecobaltous chloride results in decreased expression of PGM1 mRNA24612858
C018021cobaltous chloridecobaltous chloride results in increased expression of PGM1 mRNA22202117
C018021cobaltous chloridezinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PGM1 mRNA]22202117
C018021cobaltous chloridecobaltous chloride results in increased expression of PGM1 mRNA24386269
D016572CyclosporineCyclosporine results in decreased expression of PGM1 mRNA20106945|2163298
D003703DemecolcineDemecolcine results in decreased expression of PGM1 mRNA23649840
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PGM1 mRNA]27941970
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of PGM1 mRNA21266533
C036042dicyclohexyl phthalatedicyclohexyl phthalate affects the expression of PGM1 mRNA26924002
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of PGM1 mRNA24535843
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PGM1 mRNA"22485181
C051904dinophysistoxin 1dinophysistoxin 1 results in decreased expression of PGM1 mRNA28939011
D004147DioxinsDioxins affects the expression of PGM1 mRNA20463971
D004237DiuronDiuron results in decreased expression of PGM1 mRNA25152437
C118739entinostatentinostat results in increased expression of PGM1 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of PGM1 protein20227414
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of PGM1 mRNA17942748
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PGM1 mRNA17942748
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in decreased expression of PGM1 mRNA23649840
D004397FonofosFonofos results in increased methylation of PGM1 promoter22847954
D005557FormaldehydeFormaldehyde results in decreased expression of PGM1 mRNA23649840
D005839GentamicinsGentamicins results in decreased expression of PGM1 protein22061828
D017313FenretinideFenretinide results in decreased expression of PGM1 mRNA28973697
D006830Hydralazine[Hydralazine co-treated with Valproic Acid] results in increased expression of PGM1 mRNA17183730
C410337K 7174K 7174 results in decreased expression of PGM1 mRNA24086573
D007854LeadLead affects the expression of PGM1 mRNA28903495
D008627Mercuric ChlorideMercuric Chloride affects the expression of PGM1 mRNA20353558
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of PGM1 mRNA23179753|2718838
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of PGM1 mRNA23649840
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of PGM1 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of PGM1 mRNA"25554681
C022838nickel chloridenickel chloride affects the expression of PGM1 mRNA22110744
C029938nickel sulfatenickel sulfate results in decreased expression of PGM1 mRNA22714537
C002741N-nitrosomorpholineN-nitrosomorpholine affects the expression of PGM1 protein19716841
C464660obeticholic acidobeticholic acid results in decreased expression of PGM1 mRNA27939613
D010100OxygenOxygen deficiency results in increased expression of PGM1 mRNA24236059|2651600
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of PGM1 mRNA26272509
D010278ParathionParathion results in increased methylation of PGM1 promoter22847954
D010416PentachlorophenolPentachlorophenol results in increased expression of PGM1 mRNA24642059
D011374ProgesteroneProgesterone results in decreased expression of PGM1 mRNA23012394
C045950propiconazolepropiconazole results in increased expression of PGM1 mRNA21278054
C015586propiverinepropiverine binds to PGM1 protein29273565
C100573prostaglandin A1prostaglandin A1 analog results in increased metabolism of PGM1 protein19800325
C031280pyrazolepyrazole results in increased expression of PGM1 mRNA17945193
D011794QuercetinQuercetin results in decreased expression of PGM1 mRNA21632981
D015474IsotretinoinIsotretinoin results in decreased expression of PGM1 mRNA20436886
C017947sodium arsenitesodium arsenite results in increased expression of PGM1 mRNA23648393|2871322
D018038Sodium SeleniteSodium Selenite results in increased expression of PGM1 mRNA18175754
C041711St. Thomas' Hospital cardioplegic solutionSt. Thomas' Hospital cardioplegic solution results in increased expression of PGM1 mRNA16214533
D013629TamoxifenTamoxifen results in increased expression of PGM1 mRNA25123088
C012568terbufosterbufos results in increased methylation of PGM1 promoter22847954
C045037testosterone-3-carboxymethyloxime-bovine serum albumin conjugatetestosterone-3-carboxymethyloxime-bovine serum albumin conjugate results in increased expression of PGM1 mRNA20189893
C534735tetraarsenic tetrasulfidetetraarsenic tetrasulfide affects the expression of PGM1 protein24430359
D013749Tetrachlorodibenzodioxin2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA]23152189
D013749Tetrachlorodibenzodioxinalpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA]23152189
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA23152189
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PGM1 mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of PGM1 mRNA22298810
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA18796159|2121527
D013849ThimerosalThimerosal results in decreased expression of PGM1 mRNA27188386
C066340tolcaponetolcapone results in increased expression of PGM1 mRNA24136188
D014212TretinoinTretinoin results in decreased expression of PGM1 mRNA23774253
D014212TretinoinTretinoin results in increased expression of PGM1 mRNA21934132
C012589trichostatin Atrichostatin A results in increased expression of PGM1 mRNA15901671
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of PGM1 mRNA24935251|2627250
C012589trichostatin Atrichostatin A results in increased expression of PGM1 mRNA15901671
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of PGM1 mRNA"26179874
C080163trovafloxacintrovafloxacin results in decreased expression of PGM1 mRNA24136188
D014520UrethaneUrethane results in decreased expression of PGM1 mRNA28818685
D014635Valproic AcidValproic Acid results in increased expression of PGM1 mRNA15901671
D014635Valproic Acid[Hydralazine co-treated with Valproic Acid] results in increased expression of PGM1 mRNA17183730
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM1 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of PGM1 mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of PGM1 mRNA23179753|2438349
D014635Valproic AcidValproic Acid results in increased expression of PGM1 mRNA15901671
D014640VancomycinVancomycin results in decreased expression of PGM1 mRNA18930951
D001335Vehicle EmissionsVehicle Emissions results in decreased expression of PGM1 mRNA19165385
C025643vinclozolinvinclozolin results in increased expression of PGM1 mRNA20566332
D014750VincristineVincristine results in decreased expression of PGM1 mRNA23649840
C016837zinc chloridezinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PGM1 mRNA]22202117

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000287magnesium ion binding-IDA26972339  
GO:0004614phosphoglucomutase activity-EXP1840235  
GO:0004614phosphoglucomutase activity-IBA21873635  
GO:0004614phosphoglucomutase activity-IDA1530890  25288802  
GO:0004614phosphoglucomutase activity-TAS8257433  
GO:0005515protein binding-IPI21044950  
GO ID GO Term Qualifier Evidence PubMed
GO:0005978glycogen biosynthetic process-IBA21873635  
GO:0005978glycogen biosynthetic process-TAS-  
GO:0005980glycogen catabolic process-TAS-  
GO:0006006glucose metabolic process-IBA21873635  
GO:0006006glucose metabolic process-IDA25288802  
GO:0006006glucose metabolic process-NAS1530890  
GO:0006094gluconeogenesis-TAS8257433  
GO:0006096glycolytic process-TAS8257433  
GO:0019388galactose catabolic process-IBA21873635  
GO:0019388galactose catabolic process-TAS-  
GO:0043312neutrophil degranulation-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-TAS-  
GO:0005737cytoplasm-NAS1530890  
GO:0005829cytosol-IBA21873635  
GO:0005829cytosol-TAS-  
GO:0015629actin cytoskeleton-IDA-  
GO:0070062extracellular exosome-HDA19056867  23533145  
GO:1904724tertiary granule lumen-TAS-  
GO:1904813ficolin-1-rich granule lumen-TAS-  
KEGG ID KEGG Term
hsa00010Glycolysis / Gluconeogenesis
hsa00030Pentose phosphate pathway
hsa00052Galactose metabolism
hsa00230Purine metabolism
hsa00500Starch and sucrose metabolism
hsa00520Amino sugar and nucleotide sugar metabolism
hsa01100Metabolic pathways
Reactome ID Reactome Term Evidence
R-HSA-1430728MetabolismTAS
R-HSA-1643685DiseaseTAS
R-HSA-168249Innate Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-3322077Glycogen synthesisTAS
R-HSA-3781865Diseases of glycosylationTAS
R-HSA-5609974Defective PGM1 causes PGM1-CDG (CDG1t)TAS
R-HSA-5609975Diseases associated with glycosylation precursor biosynthesisTAS
R-HSA-6798695Neutrophil degranulationTAS
R-HSA-70221Glycogen breakdown (glycogenolysis)TAS
R-HSA-70370Galactose catabolismTAS
R-HSA-71387Metabolism of carbohydratesTAS
R-HSA-8982491Glycogen metabolismTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
8082314Fetal growth, gestation length and phosphoglucomutase-1 phenotype. (1993 Dec)Johnstone FDDis Markers
19004324[Molecular-genetic and epidemiologic examination of personnel subjected to occupational irradiation in Russian Federal Nuclear Center (Sarov). Report 1. Genome structural damage rate and radiosensitivity]. (2008 Sep-Oct)Korzeneva IBRadiats Biol Radioecol